A case of emetophobia responding to mirtazapine and propranolol treatment
Yükleniyor...
Dosyalar
Tarih
2022
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Korean Society of Neurogastroenterlogy and Motility
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Emetophobia (“phobia of vomiting and nausea” or “Specific Phobia- Other [Vomiting]” in Diagnostic and statistical manual of mental disorders-Fifth Edition [DSM-5]) is characterized by impairing, chronic phobic avoidance of nausea/vomiting as well as inordinate cognitive and autonomic responses when avoidance is not possible.1,2 Patients may have elevated disgust sensitivity, a tendency to display gastrointestinal symptoms of anxiety as well as misinterpretation of those symptoms as catastrophic.2 Data on pharmacological management of emetophobia among adolescents is limited with only 2 cases benefiting from selective serotonin reuptake inhibitors (fluoxetine and sertraline) while adults may also benefit from benzodiazepines. 3-5 Patients may apply to various medical specialty clinics for treatment and this may delay diagnosis and management. Here; we aim to present an adolescent with emetophobia and its management by mirtazapine and propranolol.
Açıklama
Anahtar Kelimeler
Emetophobia, Serotonin, Propranolol Treatment
Kaynak
Journal of Neurogastroenterology and Motility
WoS Q Değeri
Q2
Scopus Q Değeri
Q2
Cilt
28
Sayı
4
Künye
Köksal, M., Koçak, G., Öztürk, Y., & Tufan, A. E. (2022). A Case of Emetophobia Responding to Mirtazapine and Propranolol Treatment. Journal of Neurogastroenterology and Motility, 28(4), 709-710.
